What can Parkinson’s Disease Learn from the Recent Progress in Alzheimer’s Disease? Lessons for HER-096

Time: 2:30 pm
day: Blood-Based Biomarker Focus Day


  • Learning from the recent Alzheimer’s Disease trial successes and how this can help inform PD treatment development, highlighting the importance of biomarkers
  • Understanding the importance of surrogate markers and development of clinical endpoints for a faster read on clinical trials
  • Pushing early biology and biomarker discovery to support clinical development, examples from HER-096